On October 31,‍ JPMorgan low‍ered its price target on GSK plc (NYSE:GSK) to 1,440 GBp fro⁠m 1,550 GBp w⁠hile maintaining an ...

A strong performer already, GSK stock is trading up 44% in 2025, yet its stock remains a good bargain. GSK trades for a ...

GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK has announced the repurchase of 167,000 of its own shares as part of its ongoing ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GlaxoSmithKline (GSK) has announced a recent purchase of 170,000 of its own ordinary shares ...

GSK plc (NYSE: GSK) is one of the best undervalued stocks to buy under $50. Deutsche Bank analyst Emmanuel Papadakis released ...

GSK Pharma share price fell 3 per cent after it reported a lower-than-expected top-line for the second quarter of the current financial year ...

GSK (LSE:GSK) shares have edged slightly lower as investors digest recent trading activity and look for new signals on the ...

Unsurprisingly, GSK plc's ( LON:GSK ) stock price was strong on the back of its healthy earnings report. However, ...

ALEC stock plunges after its dementia candidate fails to slow disease progression in a late-stage study, prompting job cuts and a strategic pipeline shift.

GSK plc has announced provisional dividend dates for the year 2026, outlining key dates for ordinary shares and American Depositary Shares. These dates are subject to change and provide stakeholders ...

GSK PLC's (NYSE: GSK) short interest as a percent of float has risen 6.45% since its last report. According to exchange reported data, there are now 13.33 million shares sold short, which is 0.66% of ...

Wondering if GSK is actually undervalued or if there's more to the story than recent headlines suggest? You're not alone, and we're about to dive into what those numbers really mean. Despite a slight ...